Top compounds associated with response to NMRK2


Feature Type Standardized
Nominal ANOVA
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.07 0.05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.05
mRNA GDC-0941 GDSC1000 pan-cancer AAC -0.067 0.05
mRNA ZG-10 GDSC1000 pan-cancer AAC -0.089 0.05
mRNA PD-0325901 CCLE pan-cancer AAC 0.078 0.06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.067 0.06
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.099 0.06
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA TKI258 CCLE pan-cancer AAC -0.084 0.06
Download CSV